We are live on ! Find out more
BSX icon

Boston Scientific

888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 95

1% more funds holding

Funds holding: 877888 (+11)

3% less capital invested

Capital invested by funds: $56.3B → $54.6B (-$1.66B)

10% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 322

1.09% less ownership

Funds ownership: 91.5%90.41% (-1.1%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

42% less call options, than puts

Call options by funds: $271M | Put options by funds: $467M

Holders
888
Holders Change
+11
Holders Change %
+1.25%
% of All Funds
13.67%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
121
Increased
290
Reduced
322
Closed
95
Calls
$271M
Puts
$467M
Net Calls
-$196M
Net Calls Change
-$17.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$356M +$12.6M +299,700 +4%
Amundi
27
Amundi
France
$338M -$8.7M -206,963 -3%
Newport Trust Company
28
Newport Trust Company
District of Columbia
$330M +$4.56M +108,497 +1%
Charles Schwab
29
Charles Schwab
California
$321M +$8.17M +194,378 +3%
Canada Pension Plan Investment Board
30
Canada Pension Plan Investment Board
Ontario, Canada
$318M +$9.2M +219,035 +3%
Invesco
31
Invesco
Georgia
$315M +$9.78M +232,665 +3%
N
32
Nuveen
North Carolina
$313M -$46.6M -1,107,831 -13%
Fidelity International
33
Fidelity International
Bermuda
$297M +$33.4M +794,032 +13%
Citadel Advisors
34
Citadel Advisors
Florida
$277M +$75M +1,785,342 +38%
Marshall Wace
35
Marshall Wace
United Kingdom
$270M +$227M +5,411,822 +572%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$247M -$812K -19,329 -0.3%
UBS AM
37
UBS AM
Illinois
$242M -$27.9M -664,364 -10%
O
38
OrbiMed
New York
$236M -$11.8M -281,300 -5%
Swiss National Bank
39
Swiss National Bank
Switzerland
$230M -$8.87M -211,100 -4%
UBS Group
40
UBS Group
Switzerland
$226M +$23M +548,414 +12%
Morgan Stanley
41
Morgan Stanley
New York
$207M +$3.89M +92,629 +2%
JFL
42
Jarislowsky, Fraser Ltd
Quebec, Canada
$188M +$367K +8,742 +0.2%
PAMS
43
Pictet Asset Management (Switzerland)
Switzerland
$184M +$8.63M +205,258 +5%
Prudential Financial
44
Prudential Financial
New Jersey
$178M -$7.37M -175,398 -4%
SEI Investments
45
SEI Investments
Pennsylvania
$178M -$760K -18,091 -0.4%
Neuberger Berman Group
46
Neuberger Berman Group
New York
$176M -$10.2M -242,190 -6%
Two Sigma Investments
47
Two Sigma Investments
New York
$174M -$23.2M -550,951 -12%
Wells Fargo
48
Wells Fargo
California
$166M -$166M -3,944,533 -50%
Sumitomo Mitsui Trust Group
49
Sumitomo Mitsui Trust Group
Japan
$166M -$7M -166,700 -4%
DCP
50
DSM Capital Partners
Florida
$164M -$11.4M -271,157 -7%

BSX Hedge Fund Activity: Q4 2021 in Review

888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.

  • 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
  • Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
  • 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
  • The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
  • The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.

Based on aggregated 13F filings for Q4 2021.